Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: Disease expression in relation to age, gender, and long term outcome

Circulation: Cardiovascular Genetics

Volumn 5, Issue 2, 2012, Pages 156-166

  Page, Stephen P ^a   Kounas, Stavros ^a   Syrris, Petros ^a   Christiansen, Michael ^b   Frank Hansen, Rune ^b   Andersen, Paal Skytt ^b   Elliott, Perry M ^a   McKenna, William J ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Disease expression; Genetic heart disease; Hypertrophic cardiomyopathy; MYBPC3; Penetrance

Indexed keywords

CARDIAC MYOSIN BINDING PROTEIN C; DNA; MYOSIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL EVALUATION; DNA EXTRACTION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GENE EXPRESSION; GENETIC DISORDER; GENETIC HETEROGENEITY; GENETIC SCREENING; HEART LEFT VENTRICLE HYPERTROPHY; HETEROZYGOSITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INDEL MUTATION; INTRON; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MORTALITY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEX RATIO; SUDDEN DEATH; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PEDIGREE; PENETRANCE; SEX FACTORS; YOUNG ADULT;

EID: 84860818609     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.111.960831     Document Type: Article

References (34)

1. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA Study: Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785-789.
2. Keren A, Syrris P, McKenna WJ. Hypertrophic cardiomyopathy: The genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med. 2008;5:158-168.
3. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M : EUROGENE Heart Failure Project. Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation. 2003;107:2227-2232. (Pubitemid 36547217)
4. Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2001;22:655-670. (Pubitemid 32538979)
5. Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Sarcomeric genotyping in hypertrophic cardiomyopathy. Mayo Clin Proc. 2005;80:463-469. (Pubitemid 40471377)
6. Erdmann J, Daehmlow S, Wischke S, Senyuva M, Werner U, Raible J, Tanis N, Dyachenko S, Hummel M, Hetzer R, Regitz-Zagrosek V. Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Clin Genet. 2003;64:339-349. (Pubitemid 37236134)
7. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med. 1998;338:1248-1257. (Pubitemid 28216578)
8. Charron P, Dubourg O, Desnos M, Bennaceur M, Carrier L, Camproux A-C, Isnard R, Hagege A, Langlard JM, Bonne G, Richard P, Hainque B, Bouhour JB, Schwartz K, Komajda M. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation. 1998;97: 2230-2236. (Pubitemid 28265384)
9. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, Wigle ED: Task Force on Clinical Expert Consensus Documents. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42: 1687-1713. (Pubitemid 37383745)
10. Frank-Hansen R, Page SP, Syrris P, McKenna WJ, Christiansen M, Andersen PS. Micro-exons of the cardiac myosin binding protein C gene: Flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations. Eur J Hum Genet. 2008;16: 1062-1069.
11. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: Proposal for new diagnostic criteria in adult members of affected families. Heart. 1997;77: 130-132. (Pubitemid 27115795)
12. Charron P, Dubourg O, Desnos M, Isnard R, Hagege A, Millaire A, Carrier L, Bonne G, Tesson F, Richard P, Bouhour JB, Schwartz K, Komajda M. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation. 1997;96:214-219. (Pubitemid 27298423)
13. Romhilt DW, Estes EH Jr. A point score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J. 1968;75:752.
14. Mogensen J, Bahl A, Kubo T, Elanko N, Taylor R, McKenna WJ. Comparison of fluorescent SSCP and denaturing HPLC analysis with direct sequencing for mutation screening in hypertrophic cardiomyopathy. J Med Genet. 2003;40:e59.
15. Andersen PS, Havndrup O, Bundgaard H, Larsen LA, Vuust J, Pedersen AK, Kjeldsen K, Christiansen M. Genetic and phenotypic characterization of mutations in myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic cardiomyopathy: Total or partial haploinsufficiency. Eur J Hum Genet. 2004;12:673-677. (Pubitemid 39172430)
16. Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ, Ackerman MJ. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004; 44:1903-1910. (Pubitemid 39424094)
17. Saltzman AJ, Mancini-DiNardo D, Li C, Chung WK, Ho CY, Hurst S, Wynn J, Care M, Hamilton RM, Seidman GW, Gorham J, McDonough B, Sparks E, Seidman JG, Seidman CE, Rehm HL. The cardiac myosin binding protein C Arg502Trp mutation: A common cause of hypertrophic cardiomyopathy. Circ Res. 2010;106:1549-1552.
18. Cardim N, Perrot A, Santos S, Morgado P, Padua M, Ferreira S, Reis RP, Monteiro C, Ferreira T, Correia JM, Osterziel KJ. Hypertrophic cardiomyopathy in a Portuguese population: Mutations in the myosin-binding protein C gene. Rev Port Cardiol. 2005;24:1463-1476. (Pubitemid 43342155)
19. Elliott PM, McKenna WJ. Hypertrophic cardiomyopathy. Lancet. 2004; 363:1881-1891. (Pubitemid 38748646)
20. Maron BJ. Hypertrophic cardiomyopathy: A systematic review. JAMA. 2002;287:1308-1320. (Pubitemid 34250486)
21. Maron BJ, Spirito P, Wesley Y, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med. 1986;315:610-614. (Pubitemid 16046974)
22. Maron BJ, Niimura H, Casey SA, Soper MK, Wright GB, Seidman JG, Seidman CE. Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol. 2001;38:315-321. (Pubitemid 32721755)
23. Nagueh SF, McFalls J, Meyer D, Hill R, Zoghbi WA, Tam JW, Quinones MA, Roberts R, Marian AJ. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with sub-clinical disease. Circ. 2003;108:395-398. (Pubitemid 36935530)
24. Olivotto I, Maron MS, Adabag S, Casey SA, Vargiu D, Link MS, Udelson JE, Cecchi F, Maron BJ Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46:480-487. (Pubitemid 41040290)
25. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ. Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol. 2000;36: 2212-2218.
26. Christiaans I, Birnie E, van Langen IM, van Spaendonck-Zwarts KY, van Tintelen JP, van den Berg MP, Atsma DE, Helderman-van den Enden AT, Pinto YM, Hermans-van Ast JF, Bonsel GJ, Wilde AA. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: Focus on predictive screening. Eur Heart J. 2010;31:842-848.
27. Malhotra A, Buttrick P, Scheuer J. Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats. Am J Physiol. 1990;259:866-871.
28. Marian AJ. Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol. 2002;17:242-252. (Pubitemid 34553628)
29. Kubo T, Kitaoka H, Okawa M, Matsumura Y, Hitomi N, Yamasaki N, Furuno T, Takata J, Nishinaga M, Kimura A, Doi YL. Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac myosin-binding protein C gene among Japanese. J Am Coll Cardiol. 2005;46: 1737-1743. (Pubitemid 41531632)
30. Konno T, Shimizu M, Hidekazu I, Matsuyama T, Yamaguchi M, Terai H, Hayashi K, Mabuchi T, Kiyama M, Sakata K, Hayashi T, Inoue M, Kaneda T, Mabuchi H. A novel missense mutation in the myosin bonding protein C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients. J Am Coll Cardiol. 2003;41:781-786. (Pubitemid 36308385)
31. Maron BJ, Olivotto I, Bellone P, Conte MR, Cecchi F, Flygenring BP, Casey SA, Gohman TE, Bongioanni S, Spirito P. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;39:301-307. (Pubitemid 34084637)
32. Maron BJ, Olivotto I, Spirito P, Casey SA, Bellone P, Gohman TE, Graham KJ, Burton DA, Cecchi F. Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population. Circulation. 2000;102:858-864.
33. Mogensen J, Murphy RT, Kubo T, Bahl A, Moon JC, Klausen IC, Elliott PM, McKenna WJ. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;44:2315-2325. (Pubitemid 39647604)
34. Girolami F, Olivotto I, Passerini I, Zachara E, Nistri S, Re F, Fantini S, Baldini K, Torricelli F, Cecchi F. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy. J Cardiovasc Med. 2006;7:601-607. (Pubitemid 44350495)